EDGAR Filing Documents for 0000905718-12-000143

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0000905718-12-000143

Filing Date

2012-05-14

Accepted

2012-05-14 17:27:08

Documents

Group Members

ABINGWORTH BIOVENTURES IV EXECUTIVES LPABINGWORTH BIOVENTURES IV LP

Document Format Files

Seq	Description	Document	Type	Size
1	SUPERNUS PHARM 13D	supernus13dmay12.htm	SC 13D	236932
	Complete submission text file	0000905718-12-000143.txt		238368

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN

Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 20 7534 1508

Abingworth Management LTD (Filed by) CIK: 0001291892 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850

Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500

SUPERNUS PHARMACEUTICALS INC (Subject) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D | Act: 34 | File No.: 005-86843 | Film No.: 12839915
SIC: 2834 Pharmaceutical Preparations